|
|
Volumn 60, Issue 3, 2016, Pages 1695-1701
|
|
Efficacy and Safety of AFN-1252, the First Staphylococcus-Specific Antibacterial Agent, in the Treatment of Acute Bacterial Skin and Skin Structure Infections, Including Those in Patients with Significant Comorbidities
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AFN 1252;
ALANINE AMINOTRANSFERASE;
AMOXICILLIN;
AMPICILLIN;
ANTIINFECTIVE AGENT;
ASPARTATE AMINOTRANSFERASE;
UNCLASSIFIED DRUG;
API 1252;
BENZOFURAN DERIVATIVE;
ENOYL ACYL CARRIER PROTEIN REDUCTASE (NADH);
PYRONE DERIVATIVE;
ABDOMINAL PAIN;
ABSCESS;
ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTION;
ADULT;
AGED;
ARTICLE;
CELLULITIS;
COMORBIDITY;
DIARRHEA;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
ERYTHEMA;
FEMALE;
HEADACHE;
HUMAN;
INFESTATION;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MALE;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MINIMUM INHIBITORY CONCENTRATION;
MULTICENTER STUDY;
MYCOSIS;
NAUSEA;
NONHUMAN;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SIDE EFFECT;
SKIN DISEASE;
SKIN INDURATION;
SKIN INFECTION;
STAPHYLOCOCCAL SKIN INFECTION;
TACHYCARDIA;
THROMBOCYTOPENIA;
TREATMENT RESPONSE;
VOMITING;
WOUND;
ANTAGONISTS AND INHIBITORS;
CLINICAL TRIAL;
DRUG EFFECTS;
MICROBIOLOGY;
MIDDLE AGED;
SKIN;
SKIN DISEASES, INFECTIOUS;
STAPHYLOCOCCAL INFECTIONS;
TREATMENT OUTCOME;
YOUNG ADULT;
ADULT;
AGED;
ANTI-BACTERIAL AGENTS;
BENZOFURANS;
COMORBIDITY;
ENOYL-(ACYL-CARRIER-PROTEIN) REDUCTASE (NADH);
FEMALE;
HUMANS;
MALE;
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;
MIDDLE AGED;
PYRONES;
SKIN;
SKIN DISEASES, INFECTIOUS;
STAPHYLOCOCCAL INFECTIONS;
TREATMENT OUTCOME;
YOUNG ADULT;
|
|
EID: 84960395203
PISSN: 00664804
EISSN: 10986596
Source Type: Journal
DOI: 10.1128/AAC.01741-15 Document Type: Article |
|
Times cited : (43)
|
|
References (11)
|
